Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 58

Sort by

Sort Order Select

Journal Articles

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Monzr M. Al Malki, Ni-Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai, Thai Cao, Haris Ali, Amandeep Salhotra, Shukaib Arslan, Ibrahim Aldoss, Nicole Karras, Chatchada Karanes, Jasmine Zain, Samer Khaled, Anthony Stein, David Snyder, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura

Blood Adv (2021) 5 (12): 2650–2659.

https://doi.org/10.1182/bloodadvances.2021004192

Published: 2021

Includes: Supplemental data

Journal Articles

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide

Amy E. DeZern, Clio Franklin, Hua-Ling Tsai, Phil Hollingsworth Imus, Kenneth R. Cooke, Ravi Varadhan, Richard J. Jones

Blood Adv (2021) 5 (5): 1360–1368.

https://doi.org/10.1182/bloodadvances.2020003922

Published: 2021

Includes: Supplemental data

Journal Articles

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Luisa Strocchio, Daria Pagliara, Mattia Algeri, Giuseppina Li Pira, Francesca Rossi, Valentina Bertaina, Giovanna Leone, Rita Maria Pinto, Marco Andreani, Emanuele Agolini, Katia Girardi, Stefania Gaspari, Lavinia Grapulin, Francesca del Bufalo, Antonio Novelli, Pietro Merli, Franco Locatelli

Blood Adv (2021) 5 (5): 1333–1339.

https://doi.org/10.1182/bloodadvances.2020003707

Published: 2021

Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Blood Adv (2021) 5 (5): 1154–1163.

https://doi.org/10.1182/bloodadvances.2020003779

Published: 2021

Journal Articles

Low 5-year health care burden after umbilical cord blood transplantation

Jesus Garcia Garcia, Sonya Grillo, Qing Cao, Claudio G. Brunstein, Mukta Arora, Margaret L. MacMillan, John E. Wagner, Daniel J. Weisdorf, Shernan G. Holtan

Blood Adv (2021) 5 (3): 853–860.

https://doi.org/10.1182/bloodadvances.2020003369

Published: 2021

Journal Articles

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Suhag Parikh, Joel A. Brochstein, Einat Galamidi, Aurélie Schwarzbach, Joanne Kurtzberg

Blood Adv (2021) 5 (3): 843–852.

https://doi.org/10.1182/bloodadvances.2020003248

Published: 2021

Includes: Supplemental data

Journal Articles

Naive T-cell depletion in stem cell transplantation

Marie Bleakley

Blood Adv (2020) 4 (19): 4980.

https://doi.org/10.1182/bloodadvances.2020001888

Published: 2020

Includes: Supplemental data

Journal Articles

Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant

Pingping Zheng, John Tamaresis, Govindarajan Thangavelu, Liwen Xu, Xiaoqing You, Bruce R. Blazar, Robert S. Negrin, James L. Zehnder, Bettina P. Iliopoulou, Everett H. Meyer

Blood Adv (2020) 4 (17): 4232–4243.

https://doi.org/10.1182/bloodadvances.2019000977

Published: 2020

Includes: Supplemental data

Journal Articles

Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study

Moshe Yeshurun, Uri Rozovski, Oren Pasvolsky, Ofir Wolach, Ron Ram, Odelia Amit, Tsila Zuckerman, Anat Pek, Maly Rubinstein, Michal Sela-Navon, Pia Raanani, Liat Shargian-Alon

Blood Adv (2020) 4 (16): 3822–3828.

https://doi.org/10.1182/bloodadvances.2020002039

Published: 2020

Journal Articles

Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant

Scott R. Solomon, Melhem Solh, Xu Zhang, Stacey Brown, Katelin C. Jackson, H. Kent Holland, Lawrence E. Morris, Asad Bashey

Blood Adv (2020) 4 (15): 3669–3676.

https://doi.org/10.1182/bloodadvances.2020001958

Published: 2020

Includes: Supplemental data

Journal Articles

Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study

Filippo Milano, Jonathan A. Gutman, H. Joachim Deeg, Eneida R. Nemecek, Joachim Baumgart, Laurel Thur, Ann Dahlberg, Rachel B. Salit, Corinne Summers, Frederick R. Appelbaum, Colleen Delaney

Blood Adv (2020) 4 (14): 3302–3310.

https://doi.org/10.1182/bloodadvances.2020002222

Published: 2020

Includes: Supplemental data

Journal Articles

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Zheng Zhou, Rajneesh Nath, Jan Cerny, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel-Azim, Vaibhav Agrawal, Gulrayz Ahmed, A. Samer Al-Homsi, Mahmoud Aljurf, Hassan B. Alkhateeb, Amer Assal, Ulrike Bacher, Ashish Bajel, Qaiser Bashir, Minocher Battiwalla, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Hannah Choe, Edward Copelan, Corey Cutler, Moussab B. Damlaj, Zachariah DeFilipp, Marcos De Lima, Miguel Angel Diaz, Nosha Farhadfar, James Foran, César O. Freytes, Aaron T. Gerds, Usama Gergis, Michael R. Grunwald, Zartash Gul, Mehdi Hamadani, Shahrukh Hashmi, Mark Hertzberg, Gerhard C. Hildebrandt, Nasheed Hossain, Yoshihiro Inamoto, Luis Isola, Tania Jain, Rammurti T. Kamble, Muhammad Waqas Khan, Mohamed A. Kharfan-Dabaja, Partow Kebriaei, Natasha Kekre, Nandita Khera, Hillard M. Lazarus, Jane L. Liesveld, Mark Litzow, Hongtao Liu, David I. Marks, Rodrigo Martino, Vikram Mathews, Asmita Mishra, Hemant S. Murthy, Arnon Nagler, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Rebecca Olin, Richard F. Olsson, Neil Palmisiano, Sagar S. Patel, Mrinal M. Patnaik, Attaphol Pawarode, Miguel-Angel Perales, Ioannis Politikos, Uday Popat, David Rizzieri, Brenda M. Sandmaier, Bipin N. Savani, Sachiko Seo, Nirav N. Shah, Geoffrey L. Uy, David Valcárcel, Leo F. Verdonck, Edmund K. Waller, Youjin Wang, Daniel Weisdorf, Baldeep Wirk, Eric Wong, Jean A. Yared, Wael Saber

Blood Adv (2020) 4 (13): 3180–3190.

https://doi.org/10.1182/bloodadvances.2019001266

Published: 2020

Includes: Supplemental data

Journal Articles

Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders

Mark T. Vander Lugt, Xiaohua Chen, Maria L. Escolar, Beth A. Carella, Jessie L. Barnum, Randy M. Windreich, Memphis J. Hill, Michelle Poe, Rebecca A. Marsh, Heather Stanczak, Elizabeth O. Stenger, Paul Szabolcs

Blood Adv (2020) 4 (13): 3041–3052.

https://doi.org/10.1182/bloodadvances.2020001940

Published: 2020

Includes: Supplemental data

Journal Articles

Ritz C, Meng W, Stanley NL, et al. Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8 + lymphocytes. Blood Adv. 2020;4(7):1378-1382.

Blood Adv (2020) 4 (13): 2865.

https://doi.org/10.1182/bloodadvances.2020002586

Published: 2020

Journal Articles

Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia

Blood Adv (2020) 4 (8): 1760–1769.

https://doi.org/10.1182/bloodadvances.2019001210

Published: 2020

Journal Articles

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Amy E. DeZern, Marianna L. Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños-Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky

Blood Adv (2020) 4 (8): 1770–1779.

https://doi.org/10.1182/bloodadvances.2020001729

Published: 2020

Includes: Supplemental data

Journal Articles

Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8 + lymphocytes

Caitlin Ritz, Wenzhao Meng, Natasha L. Stanley, Miren L. Baroja, Chong Xu, Patrick Yan, Alexander C. Huang, Ryan Hausler, Peter Nicholas, Jian-Meng Fan, David Lieberman, Beatriz M. Carreno, Eline T. Luning Prak, Timothy S. Olson, Daria V. Babushok

Blood Adv (2020) 4 (7): 1378–1382.

https://doi.org/10.1182/bloodadvances.2019000853

Published: 2020

Includes: Supplemental data

Journal Articles

Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation

Taiki Ando, Takayoshi Tachibana, Masatsugu Tanaka, Taisei Suzuki, Yasufumi Ishiyama, Satoshi Koyama, Eriko Ogusa, Ayumi Numata, Kenji Matsumoto, Heiwa Kanamori, Hideaki Nakajima

Blood Adv (2020) 4 (2): 408–419.

https://doi.org/10.1182/bloodadvances.2019001021

Published: 2020

Includes: Supplemental data

Journal Articles

Robust CD4 + T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin

Ioannis Politikos, Jessica A. Lavery, Patrick Hilden, Christina Cho, Taylor Borrill, Molly A. Maloy, Sergio A. Giralt, Marcel R. M. van den Brink, Miguel-Angel Perales, Juliet N. Barker

Blood Adv (2020) 4 (1): 191–202.

https://doi.org/10.1182/bloodadvances.2019000836

Published: 2020

Includes: Supplemental data

Journal Articles

Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study

Emma Das-Gupta, Kirsty J. Thomson, Adrian J. C. Bloor, Andrew D. Clark, Stephen Mackinnon, Irfan Kayani, Laura Clifton-Hadley, Pip Patrick, Nadjet El-Mehidi, Anthony Lawrie, Amy A. Kirkwood, Nigel H. Russell, David C. Linch, Karl S. Peggs

Blood Adv (2019) 3 (24): 4264–4270.

https://doi.org/10.1182/bloodadvances.2019001016

Published: 2019

NARROW

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Low 5-year health care burden after umbilical cord blood transplantation

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Naive T-cell depletion in stem cell transplantation

Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant

Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study

Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant

Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders

Ritz C, Meng W, Stanley NL, et al. Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8 + lymphocytes. Blood Adv. 2020;4(7):1378-1382.

Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8 + lymphocytes

Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation

Robust CD4 + T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin

Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only